(19)
(11) EP 3 142 017 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
31.10.2018 Bulletin 2018/44

(45) Mention of the grant of the patent:
05.09.2018 Bulletin 2018/36

(21) Application number: 16193325.4

(22) Date of filing: 25.09.2012
(51) International Patent Classification (IPC): 
H04L 12/24(2006.01)
H04L 12/911(2013.01)
H04L 12/703(2013.01)
 H04L 12/26(2006.01)
H04L 12/707(2013.01)
G06F 15/16(2006.01)

(54)

NETWORK CONNECTIVITY METHODS AND SYSTEMS

VERFAHREN UND SYSTEME FÜR NETZWERKKONNEKTIVITÄT

PROCÉDÉS ET SYSTÈMES DE CONNECTIVITÉ RÉSEAU

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.09.2011 US 201113244836

(43) Date of publication of application:
15.03.2017 Bulletin 2017/11

(60) Divisional application:
18192579.3

(62) Application number of the earlier application in accordance with Art. 76 EPC:
12836129.2 / 2761488

(73) Proprietor: Theranos IP Company, LLC
Newark, CA 94560 (US)

(72) Inventor:
  • BALWANI, Sunny
    Palo Alto, CA California 94301 (US)

(74) Representative: Avidity IP 
Broers Building Hauser Forum 21 JJ Thomson Avenue
Cambridge CB3 0FA
Cambridge CB3 0FA (GB)


(56) References cited: : 
EP-A1- 1 995 918
WO-A1-2007/099414
 WO-A1-00/74313
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).